We found that Migraine prevalence is high in BD (29%) and is associated with a more severe clinical burden that includes increased comorbidity with pain and inflammatory conditions
p = 0.052)
Thnh phn trong vin Glutathione Now: - Glutathione.500mg - Milk Thistle100mg - ALA.50mg Cng dng ca Vin ung trng da Glutathione Now 500mg: B sung glutathione - cht chng oxy ha cc mnh bo v c th Thi c t, thi ch, kim loi ra ngoi, tng cng chc nng gan Tng cng h min dch Nng tng da sng hng, t nhin ton thn Lm m nm, tn nhang, vt thm, gip da u mu rng r H tr phc hi vng da chy nng, sm mu Tng cng sc sng cho da, lm chm qu trnh lo ha, bo v da trc cc tc nhn gy hi Ngn nga v gim tnh trng da b mn nht, d ng, mn nga Tng cng nng lng cho c th, lm gim mt mi, ci thin sc khe
This represents a boundary case where regulatory flexibility, combined with restricted labeling, enabled approval despite pharmacokinetic constraints that would preclude approval for most indications ( FIGURE 1 3.4 Sensitivity analysis: effects of bioavailability improvements and dosing frequency A legitimate question arises: could modest improvements in bioavailability or modified dosing strategies overcome the half-life constraint